Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.
2.

Artificial cells: from basic science to applications.

Xu C, Hu S, Chen X.

Mater Today (Kidlington). 2016 Nov;19(9):516-532. doi: 10.1016/j.mattod.2016.02.020.

3.

Is CD47 an innate immune checkpoint for tumor evasion?

Liu X, Kwon H, Li Z, Fu YX.

J Hematol Oncol. 2017 Jan 11;10(1):12. doi: 10.1186/s13045-016-0381-z. Review.

4.

"Marker of Self" CD47 on lentiviral vectors decreases macrophage-mediated clearance and increases delivery to SIRPA-expressing lung carcinoma tumors.

Sosale NG, Ivanovska II, Tsai RK, Swift J, Hsu JW, Alvey CM, Zoltick PW, Discher DE.

Mol Ther Methods Clin Dev. 2016 Dec 7;3:16080. doi: 10.1038/mtm.2016.80.

5.

Silencing of CD47 and SIRPα by Polypurine reverse Hoogsteen hairpins to promote MCF-7 breast cancer cells death by PMA-differentiated THP-1 cells.

Bener G, J Félix A, Sánchez de Diego C, Pascual Fabregat I, Ciudad CJ, Noé V.

BMC Immunol. 2016 Sep 26;17(1):32.

6.

Cd47-Sirpα interaction and IL-10 constrain inflammation-induced macrophage phagocytosis of healthy self-cells.

Bian Z, Shi L, Guo YL, Lv Z, Tang C, Niu S, Tremblay A, Venkataramani M, Culpepper C, Li L, Zhou Z, Mansour A, Zhang Y, Gewirtz A, Kidder K, Zen K, Liu Y.

Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5434-43. doi: 10.1073/pnas.1521069113.

7.

CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer.

Zhao H, Wang J, Kong X, Li E, Liu Y, Du X, Kang Z, Tang Y, Kuang Y, Yang Z, Zhou Y, Wang Q.

Sci Rep. 2016 Jul 14;6:29719. doi: 10.1038/srep29719.

8.

Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes.

Qie Y, Yuan H, von Roemeling CA, Chen Y, Liu X, Shih KD, Knight JA, Tun HW, Wharen RE, Jiang W, Kim BY.

Sci Rep. 2016 May 19;6:26269. doi: 10.1038/srep26269.

9.

The use of CD47-modified biomaterials to mitigate the immune response.

Tengood JE, Levy RJ, Stachelek SJ.

Exp Biol Med (Maywood). 2016 May;241(10):1033-41. doi: 10.1177/1535370216647130.

10.

Durable antitumor responses to CD47 blockade require adaptive immune stimulation.

Sockolosky JT, Dougan M, Ingram JR, Ho CC, Kauke MJ, Almo SC, Ploegh HL, Garcia KC.

Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2646-54. doi: 10.1073/pnas.1604268113.

11.

Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer.

Orozco-Morales M, Soca-Chafre G, Barrios-Bernal P, Hernández-Pedro N, Arrieta O.

Mediators Inflamm. 2016;2016:3494608. doi: 10.1155/2016/3494608. Review.

12.

Original insights on thrombospondin-1-related antireceptor strategies in cancer.

Jeanne A, Schneider C, Martiny L, Dedieu S.

Front Pharmacol. 2015 Oct 29;6:252. doi: 10.3389/fphar.2015.00252. Review.

13.

Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses.

Yi T, Li J, Chen H, Wu J, An J, Xu Y, Hu Y, Lowell CA, Cyster JG.

Immunity. 2015 Oct 20;43(4):764-75. doi: 10.1016/j.immuni.2015.08.021.

14.

Perspective on Adeno-Associated Virus Capsid Modification for Duchenne Muscular Dystrophy Gene Therapy.

Nance ME, Duan D.

Hum Gene Ther. 2015 Dec;26(12):786-800. doi: 10.1089/hum.2015.107. Review.

15.

Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential.

Liu J, Wang L, Zhao F, Tseng S, Narayanan C, Shura L, Willingham S, Howard M, Prohaska S, Volkmer J, Chao M, Weissman IL, Majeti R.

PLoS One. 2015 Sep 21;10(9):e0137345. doi: 10.1371/journal.pone.0137345.

16.

CD47 blockade triggers T cell-mediated destruction of immunogenic tumors.

Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, Xu H, Peng H, Fu YX, Xu MM.

Nat Med. 2015 Oct;21(10):1209-15. doi: 10.1038/nm.3931.

17.

CD47 on artificial structures.

Schütz C.

Aging (Albany NY). 2015 Aug;7(8):513-4. No abstract available.

PMID:
26298418
Free PMC Article
18.

Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.

Schwarz B, Madden P, Avera J, Gordon B, Larson K, Miettinen HM, Uchida M, LaFrance B, Basu G, Rynda-Apple A, Douglas T.

ACS Nano. 2015 Sep 22;9(9):9134-47. doi: 10.1021/acsnano.5b03360.

19.

Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.

Sosale NG, Spinler KR, Alvey C, Discher DE.

Curr Opin Immunol. 2015 Aug;35:107-12. doi: 10.1016/j.coi.2015.06.013. Review.

20.

Molecular Pathways: Activating T Cells after Cancer Cell Phagocytosis from Blockade of CD47 "Don't Eat Me" Signals.

McCracken MN, Cha AC, Weissman IL.

Clin Cancer Res. 2015 Aug 15;21(16):3597-601. doi: 10.1158/1078-0432.CCR-14-2520.

Supplemental Content

Support Center